Tower Research Capital (TRC)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,091
| Closed | -$2.9K | – | 6177 |
|
|
2024
Q1 | $2.9K | Sell |
1,091
-9,545
| -90% | -$25.4K | ﹤0.01% | 4968 |
|
|
2023
Q4 | $25.2K | Sell |
10,636
-70
| -0.7% | -$166 | ﹤0.01% | 3517 |
|
|
2023
Q3 | $15K | Sell |
10,706
-811
| -7% | -$1.14K | ﹤0.01% | 3642 |
|
|
2023
Q2 | $34.9K | Buy |
11,517
+8,423
| +272% | +$25.5K | ﹤0.01% | 2864 |
|
|
2023
Q1 | $20K | Buy |
3,094
+2,406
| +350% | +$15.6K | ﹤0.01% | 3464 |
|
|
2022
Q4 | $4K | Sell |
688
-6,238
| -90% | -$36.3K | ﹤0.01% | 5107 |
|
|
2022
Q3 | $83K | Buy |
6,926
+5,021
| +264% | +$60.2K | ﹤0.01% | 2724 |
|
|
2022
Q2 | $24K | Buy |
1,905
+1,117
| +142% | +$14.1K | ﹤0.01% | 3626 |
|
|
2022
Q1 | $9K | Sell |
788
-545
| -41% | -$6.23K | ﹤0.01% | 4516 |
|
|
2021
Q4 | $23K | Buy |
1,333
+801
| +151% | +$13.8K | ﹤0.01% | 3534 |
|
|
2021
Q3 | $12K | Sell |
532
-116
| -18% | -$2.62K | ﹤0.01% | 4187 |
|
|
2021
Q2 | $15K | Sell |
648
-2
| -0.3% | -$46 | ﹤0.01% | 4149 |
|
|
2021
Q1 | $20K | Buy |
+650
| New | +$20K | ﹤0.01% | 3896 |
|